X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

JOURNAL OF DRUG TARGETING

期刊標題檢索 J DRUG TARGET 最新評論: Do each original strip require internal reference, or only the target ... (2024-02-02)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[JOURNAL OF DRUG TARGETING]您好,您是該頁面的第 45417 位訪客。

期刊簡介
期刊名稱JOURNAL OF DRUG TARGETING JOURNAL OF DRUG TARGETING
LetPub Score
6.4
51 ratings
Rate

Reputation
7.6

Influence
5.3

Speed
7.0

期刊簡稱J DRUG TARGET
ISSN1061-186X
E-ISSN1029-2330
h-index80
CiteScore
CiteScoreSJRSNIPCiteScore Rank
9.100.8490.706
Subject fieldQuartilesRankPercentile
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Pharmaceutical Science
Q123 / 183

自引率 (2023-2024)0.00%自引率趨勢
掲載範囲
Journal of Drug Targeting publishes papers and reviews on all aspects of drug delivery and targeting for molecular and macromolecular drugs including the design and characterization of carrier systems (whether colloidal, protein or polymeric) for both vitro and/or in vivo applications of these drugs.

Papers are not restricted to drugs delivered by way of a carrier, but also include studies on molecular and macromolecular drugs that are designed to target specific cellular or extra-cellular molecules. As such the journal publishes results on the activity, delivery and targeting of therapeutic peptides/proteins and nucleic acids including genes/plasmid DNA, gene silencing nucleic acids (e.g. small interfering (si)RNA, antisense oligonucleotides, ribozymes, DNAzymes), as well as aptamers, mononucleotides and monoclonal antibodies and their conjugates. The diagnostic application of targeting technologies as well as targeted delivery of diagnostic and imaging agents also fall within the scope of the journal. In addition, papers are sought on self-regulating systems, systems responsive to their environment and to external stimuli and those that can produce programmed, pulsed and otherwise complex delivery patterns.
官方網站http://www.tandfonline.com/toc/idrt20/current
在線稿件提交https://mc.manuscriptcentral.com/gdrt
開放訪問No
出版商Informa Healthcare
主題領域医学
出版國/地區ENGLAND
發行頻率隔月刊行
創刊年1993
每年文章數69每年文章數趨勢
黃金OA百分比2.21%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
PHARMACOLOGY & PHARMACYSCIEQ169/354
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1061-186X%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Average 2 Month(s)
競爭力 *來自作者的數據: About 75%
參考鏈接
相關期刊 【JOURNAL OF DRUG TARGETING】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    PHARMACOLOGICAL REVIEWSH-index: 210

    CiteScore: 34.70
    DRUG RESISTANCE UPDATESH-index: 100

    CiteScore: 26.20
    ADVANCED DRUG DELIVERY REVIEWSH-index: 278

    CiteScore: 28.10
    TRENDS IN PHARMACOLOGICAL SCIENCESH-index: 201

    CiteScore: 23.90
    PHARMACOLOGY & THERAPEUTICSH-index: 180

    CiteScore: 23.00
    MEDICINAL RESEARCH REVIEWSH-index: 119

    CiteScore: 29.30
    PHARMACOLOGICAL RESEARCHH-index: 118

    CiteScore: 18.70
    ARCHIVES OF PHARMACAL RESEARCHH-index: 75

    CiteScore: 13.40
    BIOMEDICINE & PHARMACOTHERAPYH-index: 78

    CiteScore: 11.90
    BRITISH JOURNAL OF PHARMACOLOGYH-index: 190

    CiteScore: 15.40
    學科內最受檢索的期刊 頁面查看次數
    BIOMEDICINE & PHARMACOTHERAPY498341
    PHYTOMEDICINE340375
    LIFE SCIENCES285851
    International Journal of Pharmaceutics242446
    PHARMACOLOGICAL RESEARCH241362
    European Journal of Pharmacology204253
    BIOCHEMICAL PHARMACOLOGY202706
    JOURNAL OF NATURAL PRODUCTS196700
    BRITISH JOURNAL OF PHARMACOLOGY165153
    MOLECULAR PHARMACEUTICS162840
  •  

    JOURNAL OF DRUG TARGETING JOURNAL OF DRUG TARGETING
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    下一頁    末頁  (頁
/2)
  [JOURNAL OF DRUG TARGETING] 的評論撰寫評論
作者: Rita Brook


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-02-02 10:11:53 評論於
Do each original strip require internal reference, or only the target protein?
(0) 讚! | Rita Brook

作者: Ogden Bernard


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-09 21:37:41 評論於
It has been 11 days since I submitted my manuscript, but it still shows as "with journal administrator." Is this normal?
(0) 讚! | Ogden Bernard

作者: Ogden Bernard


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-09 20:15:25 評論於
I submitted a review article 11 days ago, and it still shows "with journal administrator." Is this normal?
(0) 讚! | Ogden Bernard

作者: 24毕业大吉


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-09 13:21:22 評論於
What is the submission status process for this journal? It has been 11 days since the submission of the review article, and it still shows "with journal administrator." Is this normal?
(0) 讚! | 24毕业大吉

作者: 24毕业大吉


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-09 13:20:19 評論於
The overview submission has been pending for 11 days now, and it still shows "with journal administrator." Is this normal?
(0) 讚! | 24毕业大吉

作者: Ogden Bernard


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-09 09:26:54 評論於
It has been 11 days since submission, and it still shows "with journal administrator." Is this normal?
(0) 讚! | Ogden Bernard

作者: 玄冰姣妍


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-04-09 16:52:34 評論於
Three parallel original stripes with markers are needed
(0) 讚! | 玄冰姣妍

作者: 凤凰院雪柳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-01-08 17:10:33 評論於
Is the article on clinical trials accepted?
(0) 讚! | 凤凰院雪柳

作者: 凤凰院雪柳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-01-08 14:16:25 評論於
Clinical research accepted?
(0) 讚! | 凤凰院雪柳

作者: Abner Louise


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-11-01 10:48:14 評論於
This magazine gives too much power to its reviewers, and the editors do not perform basic screening of their opinions
(0) 讚! | Abner Louise

作者: Abner Louise


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-10-31 20:16:43 評論於
Research focus: sharing experience on drug targets. Submitted on July 20, 2022, received feedback on September 7, 2022, from two reviewers, both of whose comments were constructive. The editor suggested reject & resubmit based on the reviewers' feedback. After making revisions according to the reviews, we resubmitted to the same journal on September 27, 2022. Received feedback on November 1, 2022, from a single reviewer, who was extremely irresponsible and only suggested rejection due to lack of innovation. The reviewer believes that the lack of innovation is because there have been previous studies on a certain drug targeting, without mentioning the key pathological process discussed in our article. Furthermore, the reviewer questioned our drug usage method (solution or other methods) despite us clearly stating in the experimental methods section that our usage method is the same as in our previous experiments, which we have elaborated on in past articles. In conclusion, the reviewer's expertise is lacking, and we are considering writing an email to the editor to complain about this reviewer
(0) 讚! | Abner Louise

作者: 瓦咔咔


領域: 医学
審稿時間: 6.0 month(s)
結果: 修改後接受


撰寫評論

2022-07-27 09:56:23 評論於
It's pretty good. It took about four months from submission to acceptance. There were quite a few reviewers, around five or six, and their comments were also very constructive.
(0) 讚! | 瓦咔咔

作者: zhousd84


領域: 医学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2022-02-25 01:40:29 評論於
December submission, January feedback for revision, two reviewers, major revisions, there were quite a few comments, luckily the editor did a great job, and it was accepted.
(10) 讚! | zhousd84

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 22:01:24 評論於
4-6 pictures
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 15:55:05 評論於
Additive effect refers to the effect of using two drugs together is equal to the effect of using double the dose of each drug individually. If the therapeutic effect obtained by using two drugs combined is greater than the sum of the efficiency of the two single drugs, it is called a synergistic effect.
How to judge whether the interaction between two drugs is a synergistic effect or an additive effect? Due to the many factors that affect efficacy in animal experiments or clinical treatment, unless the results are significantly larger than the sum of the effectiveness of each drug, it can be clearly determined that a synergistic effect has been achieved, otherwise it is generally referred to as an enhancing effect
(0) 讚! | 维尔娜菲茨杰拉德

作者: 破戒阳平


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 23:56:21 評論於
How many figures/tables do most journals require?
(0) 讚! | 破戒阳平

作者: 陶宜三岁啦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 21:13:28 評論於
What is synergy? What is additive effect? What is the difference between the two?
(0) 讚! | 陶宜三岁啦

作者: 灵空奇希


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-11-12 23:10:30 評論於
Please submit for review
(0) 讚! | 灵空奇希

作者: 坠星惜巧


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-08-19 21:50:28 評論於
Review speed: 2.0 
Research focus: Oncology drug 
Experience sharing: Submitted for a month and still no news
(0) 讚! | 坠星惜巧

作者: 坠星惜巧


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-08-04 16:51:28 評論於
Is "under review" in the process of being reviewed or in the hands of the editor?
(0) 讚! | 坠星惜巧

作者: 灵空奇希


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-07-07 15:09:32 評論於
The editor's suggestion is to make the modifications as soon as possible, but we will take two months to do so
(0) 讚! | 灵空奇希

作者: 先天梓萱


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-05-05 21:15:16 評論於
How long did it take for you to make the revisions after the first review?
(0) 讚! | 先天梓萱

作者: 灵空奇希


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-03-12 14:14:17 評論於
Review Speed: 6.0 | Submission Hit Rate: 50.0
Experience Sharing: Submitted a review on targeted drugs, first review completed in one month, with major revisions suggested by the editor. The comments from two reviewers were constructive, and two new figures and an improved table were added as requested. Accepted after the second review two months later. Despite some difficulties, grateful for the outcome. The submission difficulty is moderate, with a total time of approximately within half a year. Graduating students may consider this option
(0) 讚! | 灵空奇希

作者: 弘光三岁啦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-03-01 15:55:12 評論於
Do you need to provide original data?
(0) 讚! | 弘光三岁啦

作者: 一吃就胖小天琪


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-07-13 09:41:44 評論於
Do you need to provide the original data?
(0) 讚! | 一吃就胖小天琪

首頁    上一頁    1    2    下一頁    末頁  (頁
/2)

開始撰寫 [JOURNAL OF DRUG TARGETING] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*